Nikhil Lalwani, PRESIDENT & CEO at ANI PHARMACEUTICALS INC (ANIP), sold 36,962 shares at $57.95 ($2.1M) on 2024-11-26, disclosed to the SEC on 2024-11-27.
Open-market sale of $2.1M ANIP by PRESIDENT & CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $57.95 | 30,000 | $1.7M | 81.1% |
| 2 | $58.30 | 3,481 | $203K | 9.5% |
| 3 | $58.30 | 3,481 | $203K | 9.5% |
| Total | $58.02 avg | 36,962 | $2.1M | 100% |
| Filing → |
| ANIP | SELL | 2026-05-13 | $4.3M | — | Filing → |
| ANIP | SELL | 2025-08-14 | $9.8M | — | Filing → |
| ANIP | SELL | 2024-05-16 | $2.2M | — | Filing → |